Evidence map›Paper›PMID 42077239›Full record

ArticleGlobal implementation research and applications2026

Disseminating a Pediatric Oncology Critical Care Intervention in Latin America and Spain: An Integrated-Knowledge-Translation Approach.

Anita V Arias, Zuley Dominguez, Ángela Puerto-Torres, María Lamia, Paola Arias-Prado, Janet Middlekauff, Ritwik Budhiraja, Yichen Chen, Eliana López-Barón, Carlos Acuña and 29 more

Abstract read
In one paragraph

Article in Global implementation research and applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

Anita V AriasDivision of Critical Care and Pulmonary Medicine, Department of Pediatrics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Zuley DominguezDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.
Ángela Puerto-TorresDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.
María LamiaDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.
Paola Arias-PradoDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.
Janet MiddlekauffDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.
Ritwik BudhirajaDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.
Yichen ChenDepartment of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA.
Eliana López-BarónUnidad de Cuidados Intensivos Pediátricos, Hospital Pablo Tobón Uribe, Medellín, Colombia.
Carlos AcuñaUnidad de Cuidados Intensivos Pediátricos, Hospital Dr. Luis Calvo Mackenna, Santiago, Chile.
Renee AlceUnidad de Cuidados Intensivos Pediátricos, St. Damien's Pediatric Hospital, Port-au-Prince, Haití.
Yvania AlfonsoUnidad de Oncohematología Pediátrica, St. Damien's Pediatric Hospital, Port-au-Prince, Haití.
Yefry Aragón-JoyaUnidad de Cuidados Intensivos Pediátricos, Instituto Nacional de Cancerología, Bogotá, Colombia.
Jocelyn BecerrilUnidad de Oncohematología Pediátrica, Hospital Materno Infantil ISSEMyM, Toluca, México.
Erika Blasco-ArriagaUnidad de Cuidados Intensivos Pediátricos, ION SOLCA, Guayaquil, Ecuador.
Alejandra CalderonUnidad de Cuidados Intensivos Pediátricos, Instituto Nacional de Cancerología, Bogotá, Colombia.
Magdalena CerdaUnidad de trasplante de precursores hematopoyéticos, Hospital Dr. Luis Calvo Mackenna, Santiago, Chile.
Romina CoronaUnidad de Oncohematología Pediátrica, Centro Provincial de Salud Infantil (CePSI) Eva Perón, Santiago del Estero, Argentina.
María Eugenia CostaUnidad de Oncohematología Pediátrica, Hospital de Niños de la Santísima Trinidad, Córdoba, Argentina.
Claudia De León GutiérrezUnidad de Cuidados Intensivos Pediátricos, Unidad Nacional de Oncología Pediátrica (UNOP), Guatemala City, Guatemala.
Arturo Estrada-LópezUnidad de Cuidados Intensivos Pediátricos, Hospital Regional de Alta Especialidad del Bajío, León Guanajuato, México.
Ligia Fu-CarrascoUnidad de Oncohematología Pediátrica, Hospital Escuela, Tegucigalpa, Honduras.
David Garay-BarbosaUnidad de Oncohematología Pediátrica, Clínica FOSCAL, Bucaramanga, Colombia.
Javier Godoy-CordobésUnidad de Cuidados Intensivos Pediátricos, Instituto Nacional de Cancerología, Bogotá, Colombia.
María González-PedrozaUnidad de Oncohematología Pediátrica, Hospital para el Niño del Instituto Materno Infantil del Estado de México, Toluca de Lerdo, México.
Catherin GrisalesUnidad de Cuidados Intensivos Pediátricos, Fundación Hospital Pediátrico La Misericordia (HOMI), Bogotá, Colombia.
Rubén E Lasso-PalominoUnidad de Cuidados Intensivos Pediátricos, Fundación Valle del Lili - Universidad ICESI, Cali, Colombia.
Rosa León-ParedesUnidad de Cuidados Intensivos Pediátricos, Instituto Nacional de Salud del Niño, Lima, Perú.
Norma A López-FacundoUnidad de Oncohematología Pediátrica, Hospital Materno Infantil ISSEMyM, Toluca, México.
Mauricio Mesa-RincónUnidad de Oncohematología Pediátrica, Instituto de Cáncer, Hospital Universitario Fundación Santa Fe de Bogotá (FSFB), Universidad de Los Andes, Bogotá DC, Colombia.
Scheybi MiraldaUnidad de Cuidados Intensivos Pediátricos, Hospital Escuela, Tegucigalpa, Honduras.
Rosario MontilvaUnidad de Oncohematología Pediátrica, Hospital Especialidades Pediátricas, Maracaibo, Venezuela.
Rodrigo Pérez-MoralesUnidad de Cuidados Intensivos Pediátricos, Fundación Hospital Pediátrico La Misericordia (HOMI), Bogotá, Colombia.
Estuardo Pineda-UrquillaUnidad de Oncohematología Pediátrica, Hospital Nacional de niños Benjamín Bloom, San Salvador, El Salvador.
María Sánchez-MartinUnidad de Cuidados Intensivos Pediátricos, Hospital Universitario La Paz, Madrid, España.
Silvio F TorresUnidad de Cuidados Intensivos Pediátricos, Hospital Universitario Austral, Pilar-Buenos Aires, Argentina.
Margarita Torres-BaqueroUnidad de Cuidados Intensivos Pediátricos, Clínica Imbanaco - Grupo Quirón, Cali, Colombia.
Sara MaloneWashington University in St. Louis, School of Public Health, St. Louis, MO, United States.
Asya AgulnikDivision of Critical Care and Pulmonary Medicine, Department of Pediatrics, St. Jude Children's Research Hospital, Memphis, TN, USA.

Funding

PROFESSIONAL ONCOLOGY EDUCATION PROGRAMR25CA023944 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SUZANNE A. GRONEMEYER · 1986 to 2026
$8.3M
NCI NIH HHS R25 CA023944
6 · The paper itself

Abstract

PROACTIVE (Pediatric Oncology Capacity Assessment Tool for Intensive Care) is a quality improvement (QI) intervention that assist pediatric onco-critical care teams identify institutional strengths and gaps, but language barriers have limited its global uptake. This study aimed to evaluate the translation, refinement, and dissemination of Spanish-PROACTIVE guided by an integrated knowledge translation (IKT) approach. We conducted a four-phase mixed-methods study including: (1) translating and piloting Spanish-PROACTIVE in 22 centers across 12 countries in Latin America and Spain, (2) identifying institutional and regional pediatric onco-critical care challenges and QI priorities, (3) assessing barriers to disseminating results, and (4) co-developing dissemination tools. The professionally translated and refined Spanish-PROACTIVE identified key institutional and common regional pediatric onco-critical care challenges including lack of multidisciplinary rounds (only 14% availability). Institutional barriers to disseminating results included limited time and resources, gaps in dissemination knowledge and skill, and lack of mentorship. These findings informed the co-development of tailored dissemination tools, including a leadership-focused slide deck and a clinical-staff-targeted infographic to support internal dissemination. Applying an IKT approach effectively addressed language and dissemination barriers, and improved accessibility and local relevance of PROACTIVE. Spanish-PROACTIVE supports consistent multilingual data collection, and its contextually tailored dissemination tools may enhance internal communication and uptake of findings across Spanish-speaking institutions. This approach offers a practical model for strengthening dissemination and accelerating uptake of intervention results in linguistically diverse, resource-constrained settings, supporting global efforts to improve outcomes for children with cancer.

Indexed as

Global healthIntegrated knowledge translationPediatric oncology critical careQuality improvement

Identifiers

PMID42077239
PMCPMC13132147

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.